Literature DB >> 3726071

Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology.

G L Klerman.   

Abstract

Keywords:  Biomedical and Behavioral Research; Mental Health Therapies

Mesh：

Substances：

Year:  1986        PMID： 3726071

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  12 in total

Review 1.  Design of clinical trials of antidepressants: should a placebo control arm be included?

Authors:  J Fritze; H J Möller
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Placebo in the investigation of psychotropic drugs, especially antidepressants.

Authors:  Stanisław Puzyński
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

3.  The role and interpretation of pilot studies in clinical research.

Authors:  Andrew C Leon; Lori L Davis; Helena C Kraemer
Journal:  J Psychiatr Res       Date:  2010-10-28       Impact factor: 4.791

4.  The use of placebos in psychiatry: a response to the draft document prepared by the Tri-Council Working Group. Canadian College of Neuropsychopharmacology.

Authors:  S N Young; L Annable
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

5.  Antidepressants and risks of suicide and suicide attempts: a 27-year observational study.

Authors:  Andrew C Leon; David A Solomon; Chunshan Li; Jess G Fiedorowicz; W H Coryell; Jean Endicott; Martin B Keller
Journal:  J Clin Psychiatry       Date:  2011-05       Impact factor: 4.384

Review 6.  Psychosocial interventions for late-life major depression: evidence-based treatments, predictors of treatment outcomes, and moderators of treatment effects.

Authors:  Dimitris N Kiosses; Andrew C Leon; Patricia A Areán
Journal:  Psychiatr Clin North Am       Date:  2011-06

7.  Risk of suicidal behavior with antidepressants in bipolar and unipolar disorders.

Authors:  Andrew C Leon; Jess G Fiedorowicz; David A Solomon; Chunshan Li; William H Coryell; Jean Endicott; Jan Fawcett; Martin B Keller
Journal:  J Clin Psychiatry       Date:  2014-07       Impact factor: 4.384

8.  A comparison of placebo responders and nonresponders in subgroups of depressive disorder.

Authors:  R J Bialik; A V Ravindran; D Bakish; Y D Lapierre
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

9.  Enhancing clinical trial design of interventions for posttraumatic stress disorder.

Authors:  Andrew C Leon; Lori L Davis
Journal:  J Trauma Stress       Date:  2009-12

10.  Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues.

Authors:  James A Blumenthal; Andrew Sherwood; Sharon D Rogers; Michael A Babyak; P Murali Doraiswamy; Lana Watkins; Benson M Hoffman; Cara O'Connell; Julie J Johnson; Seema M Patidar; Robert Waugh; Alan Hinderliter
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.